Top Anti Cancer Imported Medicine Drugs in India - Pharma Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Koselugo (Selumetinib) Medicine in India

Koselugo (Selumetinib)

Medicine name : Koselugo

Generic name : Selumetinib

Manufactured By : Astra Zeneca

Indications : Neuro Fibromatosis Type 1

Medicine Description : A MEK inhibitor approved for pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas. It targets abnormal cell growth signaling pathways, reducing tumor size and improving symptoms.

Product Introduction

Koselugo (Selumetinib) is a targeted treatment used to treat children aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). It belongs to a group of medicines called MEK inhibitors and works by blocking signals involved in the growth of these tumors.

Koselugo (Selumetinib) should be taken exactly as prescribed by your doctor. It may be taken with or without food and should be swallowed whole with water. Do not crush, chew, or open it. Regular medical check-ups and tests may be required to monitor heart function, eye health, liver function, and other aspects of your health during treatment.

Common side effects of Koselugo (Selumetinib) may include vomiting, rash, diarrhea, nausea, dry skin, muscle or joint pain, headache, inflammation around the fingernails, and fatigue. It may also cause serious heart, eye, liver, or muscle-related problems. Inform your doctor promptly if you experience vision changes, breathing difficulties, swelling, severe muscle pain, or other concerning symptoms.

Uses Of Koselugo (Selumetinib)

Treatment of Neurofibromatosis Type 1 (NF1)

Benefits Of Koselugo

Koselugo (Selumetinib) is used to treat children aged 2 years and above with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. It helps reduce tumor size and may relieve symptoms such as pain and impaired physical function. By reducing tumor burden, it may improve mobility, daily activities, and overall quality of life.

Side Effects Of Koselugo (Selumetinib)

Most side effects do not require medical attention and may improve as your body adjusts to the treatment. Consult your doctor if they persist, become severe, or cause concern.

Common Side Effects of Koselugo (Selumetinib)

  • Headache
  • Paronychia
  • Itching
  • Vomiting
  • Rash
  • Abdominal pain
  • Diarrhea
  • Nausea
  • Dry skin
  • Fatigue
How To Use Koselugo

Take Koselugo (Selumetinib) exactly as prescribed by your doctor. It may be taken with or without food. Swallow it whole with water and do not crush, chew, or open it. Take it at approximately the same time each day and follow your doctor's instructions throughout treatment.

How Koselugo (Selumetinib) Works

Koselugo (Selumetinib) works by blocking MEK proteins, which are part of a signaling pathway that controls cell growth. In neurofibromatosis type 1 (NF1), this pathway can become overactive and contribute to the growth of plexiform neurofibromas. By inhibiting MEK, Koselugo (Selumetinib) helps slow tumor growth and may reduce tumor size and related symptoms such as pain and difficulty with movement.

Storage Conditions
  • Store Koselugo capsules at or below 30°C.
  • Keep the capsules in their original bottle to protect them from moisture.
  • Keep the bottle tightly closed when not in use.
  • Protect the medicine from light and keep it out of the reach of children.
Safety Advice

AlcoholAlcohol CONSULT YOUR DOCTOR

Limit or avoid alcohol during treatment, as it may worsen side effects such as dizziness, fatigue, or stomach-related problems. Consult your doctor for personalized advice.

PregnancyPregnancy CONSULT YOUR DOCTOR

Koselugo (Selumetinib) may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for the period advised by their doctor.

BreastfeedingBreastfeeding CONSULT YOUR DOCTOR

Do not breastfeed during treatment with Koselugo (Selumetinib) and for the period recommended by your doctor.

DrivingDriving CONSULT YOUR DOCTOR

Koselugo (Selumetinib) may cause fatigue, dizziness, or vision changes that can affect alertness. Avoid driving or operating machinery if you feel affected.

KidneyKidney CAUTION

Inform your doctor if you have kidney problems before starting treatment. Your kidney function may be monitored during treatment as advised.

LiverLiver CAUTION

Tell your doctor about any liver problems before starting treatment. Liver function should be monitored regularly during treatment.

Quick Tips
  • Follow the prescribed Koselugo (Selumetinib) schedule and take each dose at the same time every day.
  • Tell your doctor about all medicines, supplements, and existing health conditions before starting treatment.
  • Maintain good hydration and take adequate rest if you experience diarrhea, nausea, or tiredness.
  • Attend regular medical appointments, including blood tests, heart assessments, and eye examinations as recommended.
  • Women who can become pregnant should use effective contraception during treatment and for at least 1 week after the last dose.
  • Read More About - Koselugo (Selumetinib) from Pharma Five.
About Pharma Five

Pharma Five, may assist patients with importing Koselugo (Selumetinib) in small quantities for personal medical use. To facilitate the import process, the applicant is required to submit an application in Form 12A along with a prescription issued by a Registered Medical Practitioner (RMP).

Pharma Five provides professional pharmaceutical facilitation to patients seeking access to Koselugo (Selumetinib), supporting the import of specialized medicines through the relevant procedures. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

References
  1. https://go.drugbank.com/drugs/DB11689
  2. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selumetinib-adults-neurofibromatosis-type-1-symptomatic-inoperable-plexiform
  3. https://www.ema.europa.eu/en/documents/product-information/koselugo-epar-product-information_en.pdf
  4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213756Orig1s005lbl.pdf
Faq

General Question

Koselugo (Selumetinib) is a prescription medicine used to treat children aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (tumors growing along nerves).

Koselugo is a MEK inhibitor that blocks specific enzymes (MEK1 and MEK2) involved in cell growth. By targeting these enzymes, it helps shrink or slow the growth of NF1-related tumors.

Koselugo is approved for pediatric patients 2 years and older with NF1 and symptomatic, inoperable plexiform neurofibromas. It must be prescribed and monitored by a healthcare professional experienced in NF1 treatment.

Koselugo is taken orally as a capsule, usually twice daily (every 12 hours) on an empty stomach—1 hour before or 2 hours after eating. The dosage is based on the patient’s body surface area.

Common side effects include diarrhea, nausea, vomiting, abdominal pain, fatigue, skin rash, dry skin, and mouth sores.

Yes, serious side effects can include heart problems, eye problems (including vision changes), liver damage, and muscle pain or weakness. Regular monitoring is required.

Koselugo is taken as long as it remains effective and is tolerated well. The treating physician will regularly assess the patient’s response and side effects to determine treatment duration.

It is best to avoid alcohol during treatment, as it may increase the risk of liver problems and worsen side effects like fatigue or nausea.

No, Koselugo may harm an unborn baby. Female patients should use effective contraception during treatment and for a period after the last dose. Breastfeeding is also not recommended.

Yes, Koselugo can interact with other medications, including certain antifungals, antibiotics, and seizure medications. Always inform your doctor about all medicines and supplements being used.

If a dose is missed, take it as soon as remembered if its within 6 hours of the scheduled time. If more than 6 hours have passed, skip the missed dose and take the next dose at the regular time. Do not double up.

No, Koselugo should be taken on an empty stomach—at least 1 hour before or 2 hours after food—for best absorption and effectiveness.

Get regular heart, eye, and liver function checks; report any unusual symptoms immediately; avoid sun exposure and use sunscreen to protect the skin.

Store Koselugo capsules at room temperature in a dry place, away from light and moisture. Keep out of reach of children.

Koselugo is available by prescription and typically dispensed through specialty pharmacies. Your doctor can guide you on how to access it through approved channels. Pharma Five assists in its procurement.

Timely Service
Doorstep Delivery
Hassle-Free Process
100% Genuine Sources